Effect of CYP3A5*3 genotype on the pharmacokinetics and antiplatelet effect of clopidogrel in healthy subjects

Nonparametrics: Statistical Methods Based on Ranks

Mitchell J. Mergenthaler, E. L. Lehmann · Technometrics · 1979 · 3.4K citations

Natural Sciences, Biostatistics, Experimental Design +11

Early and Sustained Dual Oral Antiplatelet Therapy Following Percutaneous Coronary Intervention

Steven R. Steinhubl, Peter B. Berger, J. Tift Mann et al. · JAMA · 2002 · 3.1K citations

Medicine, Cardiology, Pharmacotherapy +14

Sequence diversity in CYP3A promoters and characterization of the genetic basis of polymorphic CYP3A5 expression

Peter Kuehl, Jiong Zhang, Yvonne Lin et al. · Nature Genetics · 2001 · 2.2K citations

Life Sciences, Genetics, Molecular Biology +17

Clopidogrel for Coronary Stenting

Paul A. Gurbel, Kevin P. Bliden, Bonnie L. Hiatt et al. · Circulation · 2003 · 1.5K citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Identification and Biological Activity of the Active Metabolite of Clopidogrel

Pierre Savi, Jean‐Marie Pereillo, Marie-Françoise Uzabiaga et al. · Thrombosis and Haemostasis · 2000 · 748 citations

Medicine, Medicinal Chemistry, Pharmacology +17